Stelopharm GmbH
your reliable partner for the distribution
of pharmaceutical products
Oxytocin Grindeks
Indication: Before delivery - After delivery
Injectable / infusion solution
Injectable / infusion solution
Manufacturing in the EU region
- From Active Ingredient to Finished Product
- Security of supply through European Production
- Foundation of Grindeks
- Today, a leading pharmaceutical manufacturer in the Baltic region | Riga | Latvia
- Supplier of active pharmaceutical ingredients (manufactured in compliance with Good Manufacturing Practices) and final dosage forms
- Cooperation partner of Stelopharm
Oxytocin Grindeks is indicated for use in the following situations:
- Before delivery:
- Induction of labor for medical reasons, e.g., in cases of post-term pregnancy, premature rupture of membranes, or pregnancy-induced hypertension
(pre-eclampsia) - Stimulation of labor in cases of uterine hypotonia or weak contractions
- In early stages of pregnancy, also used as an adjuvant in the treatment of incomplete, inevitable, or missed abortion.
- Induction of labor for medical reasons, e.g., in cases of post-term pregnancy, premature rupture of membranes, or pregnancy-induced hypertension
- After delivery:
- During a cesarean section after the delivery of the baby
- Prophylaxis and treatment of postpartum uterine atony and hemorrhage
- During a cesarean section after the delivery of the baby
Oxytocin Grindeks is a colorless and clear liquid, free from visible particles, with a pH range of 3.5 – 4.5.
Oxytocin Grindeks can be administered by intramuscular (i.m.) injection or intravenous (i.v.) infusion.
For precise dosages for labor induction or uterine hypotonia, cesarean section, prophylaxis and treatment of postpartum uterine bleeding, as well as incomplete, inevitable, or missed abortion, please refer to the current product information.*
For more information on contraindications, special warnings and precautions for use, interactions with other medications, fertility, pregnancy and breastfeeding, and side effects, please consult the published product information.
Oxytocin Grindeks, Summary of Product Characteristics, as of 10/2021
The Package leaflet can be found here.